Search For

Lactylation: a novel driver of drug resistance in the tumor microenvironment

Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression

Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

The next frontier in antibody-drug conjugates: challenges and opportunities in cancer and autoimmune therapy

Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC

Modeling methods of different tumor organoids and their application in tumor drug resistance research

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

MicroRNA-mediated autophagy regulation in thyroid cancer drug resistance

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies

Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors

Acquired resistance to molecularly targeted therapies for cancer